From politics to pop culture, climate to conflict, 2024 was a year of tumbling records — but not always for the best reasons.

COPENHAGEN, Dec 18 (Reuters) - The European Union's drug regulator said it would assess two new Danish studies that link Novo Nordisk's ... proposing that cosmetic products containing talc ...

The company markets its products through subsidiaries in North America, Europe, Asia, Latin America, Africa, the Middle East and Australia. Novo Nordisk is headquartered in Bagsvaerd, Denmark. For a ...

The "Semaglutides Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This Semaglutides market report covers market characteristics, size and growth, segmentation, regional ...

It’s likely to still be there at the end of the year, but by the time the final sales figures for 2024 are tallied up, Novo Nordisk’s semaglutide is ... selling unauthorised semaglutide-containing ...

Danish pharma company Novo Nordisk, makers of weight-loss drugs Ozempic and Wegovy, plans to expand production based on a takeover of US health products manufacturer ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk and Valo Health have expanded their 16-month-old collaboration into an up-to-$4.6 billion-plus artificial ...